adr_usa_0533|ANCN|Short Name|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
adr_usa_0533|ANCN|Long Name|Anchiano Therapeutics Ltd Total Current Assets (Quarterly) (USD)|Anchiano Therapeutics Ltd Cash and Short Term Investments (Quarterly) (USD)|Anchiano Therapeutics Ltd Inventories (Quarterly) (USD)|Anchiano Therapeutics Ltd Net PP&E (Quarterly) (USD)|Anchiano Therapeutics Ltd Goodwill and Intangibles (Quarterly) (USD)|Anchiano Therapeutics Ltd Total Liabilities (Quarterly) (USD)|Anchiano Therapeutics Ltd Total Current Liabilities (Quarterly) (USD)|Anchiano Therapeutics Ltd Total Long Term Liabilities (Quarterly) (USD)|Anchiano Therapeutics Ltd Total Deposits (Quarterly) (USD)|Anchiano Therapeutics Ltd Book Value (Quarterly) (USD)|Anchiano Therapeutics Ltd Retained Earnings (Quarterly) (USD)|Anchiano Therapeutics Ltd Treasury Stock (Quarterly) (USD)|Anchiano Therapeutics Ltd EV to Revenues|Anchiano Therapeutics Ltd EV to Earnings|Anchiano Therapeutics Ltd EV to Free Cash Flow|Anchiano Therapeutics Ltd EV to Assets (Quarterly)|Anchiano Therapeutics Ltd PS Ratio|Anchiano Therapeutics Ltd PE Ratio|Anchiano Therapeutics Ltd Price to Book Value|Anchiano Therapeutics Ltd PEG Ratio|Anchiano Therapeutics Ltd Debt to Equity Ratio|Anchiano Therapeutics Ltd Dividend Yield|Anchiano Therapeutics Ltd Shareholder Yield (TTM)|Anchiano Therapeutics Ltd Percent of Shares Outstanding Short|Anchiano Therapeutics Ltd Total Receivables (Quarterly) (USD)|Anchiano Therapeutics Ltd Total Payables (Quarterly) (USD)|Anchiano Therapeutics Ltd Total Capital Stock (Quarterly) (USD)|Anchiano Therapeutics Ltd Return on Invested Capital|Anchiano Therapeutics Ltd Quality Ratio Score|Anchiano Therapeutics Ltd Momentum Score|Anchiano Therapeutics Ltd Beta (1Y)|Anchiano Therapeutics Ltd Sustainable Growth Rate (TTM)|Anchiano Therapeutics Ltd Institutional Investor Ownership Percentage|Anchiano Therapeutics Ltd Average Diluted Shares Outstanding (Quarterly)|Anchiano Therapeutics Ltd Total Employees (Annual)|Anchiano Therapeutics Ltd EPS Diluted (Quarterly) (USD)|Anchiano Therapeutics Ltd Dividend Per Share (Quarterly) (USD)|Anchiano Therapeutics Ltd Revenue (Quarterly) (USD)|Anchiano Therapeutics Ltd Gross Profit (Quarterly) (USD)|Anchiano Therapeutics Ltd SG&A Expense (Quarterly) (USD)|Anchiano Therapeutics Ltd Pre-Tax Income (Quarterly) (USD)|Anchiano Therapeutics Ltd Net Income (Quarterly) (USD)|Anchiano Therapeutics Ltd Net Interest Income (Quarterly) (USD)|Anchiano Therapeutics Ltd Price (USD)|Anchiano Therapeutics Ltd Total Return Price (USD)|Anchiano Therapeutics Ltd Enterprise Value (USD)|Anchiano Therapeutics Ltd 30-Day Average Daily Volume|Anchiano Therapeutics Ltd 1 Year Price Returns (Daily)||
adr_usa_0533|ANCN|Unit|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
adr_usa_0533|ANCN|201603||||||||||||||||||||||||||||||||||9.7784||-0.0794||||0.2386|-0.7919|-0.7919|-0.0122|||||||
adr_usa_0533|ANCN|201606||||||||||||||||||||||||||||||||||9.8234||-0.1167||||0.6481|-1.0869|-1.1419|0.0083|||||||
adr_usa_0533|ANCN|201609||||||||||||||||||||||||||||||||||10.184||-0.1465||||0.6299|-1.3901|-1.4444|-0.0578|||||||
adr_usa_0533|ANCN|201612|5.4297|4.5625||0.2134||2.3577|2.3577|0||3.2946|-52.7284||||||||||||||0.1391|2.0738|1.9238|||||||14.7994||-0.0897||||0.7225|-1.3012|-1.3274|0.0558|||||||
adr_usa_0533|ANCN|201703|4.269|3.4546||0.2161||3.1554|3.1554|0||1.3413|-58.3159||||||||||||||0.8144|2.944|2.0423|||||||14.7994||-0.1518||||0.7998|-2.2802|-2.3382|-0.2004|||||||
adr_usa_0533|ANCN|201706|5.4247|5.0405||0.2139||2.741|2.741|0||2.9068|-64.3314||||||||||||||0.3842|2.5274|2.7562|||||||1.8886||-2.007||||0.7546|-3.6491|-3.7483|0.0229|||||||
adr_usa_0533|ANCN|201709|3.7683|3.3351||0.2232||2.8824|2.8824|0||1.1188|-65.5041||||||||||||||0.4332|2.7181|2.7235|||||||1.9078||-1||||0.777|-1.868|-1.925|0.034|||||||
adr_usa_0533|ANCN|201712|1.854|1.454||0.219||2.696|2.696|0||-0.609|-62.876||||||||||||||0.088|0.16|0|||||||1.9304||-1||||0.875|-1.835|-1.948|0.134|||||||
adr_usa_0533|ANCN|201803|1.3156|0.6689||0.2463||5.647|5.647|0||-3.9107|-71.2904||||||||||||||0.6467|5.4978|2.7375|||||||19.2262||-0.1841||||0.926|-3.477|-3.539|-0.076|||||||
adr_usa_0533|ANCN|201806|20.8514|19.4887||0.2712||18.7443|12.2279|6.5164||2.5884|-73.5844||||||||||||||1.3627|6.3406|0|||||||1.9358||-2.75||||2.287|-4.968|-5.298|-0.806|||||||
adr_usa_0533|ANCN|201809|13.921|10.912||0.347||14.97|9.96|5.01||0.233|-74.346||||||||||||||3.009|2.416|0|||||||3.1148||-0.85||||1.133|-2.565|-2.633|-0.06|||||||
adr_usa_0533|ANCN|201812|10.92|7.517||0.385||2.956|2.746|0.21||9.805|-78.307||||||||||||||3.403|0.396|0|||||||3.1076|19|-0.55||||1.175|-2.483|-2.328|0.958||||||10.8|10.8
adr_usa_0533|ANCN|201903|33.354|||||10.432|4.75|5.682||26.348|||||-2.9718||||5.1421|||0||0.4002||||||||||5.2675||-1.9||||1.291|-9.913|-9.913|-4.487|6.795|6.795|42.9012|17908.7333||6.96|6.96
adr_usa_0533|ANCN|201906|27.895|27.01||1.993||6.173|3.239|2.934||24.883|-96.404||||-2.2226||||1.2616|||0||0.1465|0.885|2.001|0|||||||7.4199||-0.6||||1.962|-4.439|-4.439|0.099|4.48|4.48|33.2412|5268.6||4.48|4.48
adr_usa_0533|ANCN|201909|24.478|23.242||1.936|3.346|21.571|15.313|6.258||9.286|-112.322||||0.4556||||1.8372|||0||0.0933|1.236|4.675|0|||||||7.4198||-2.15||||1.664|-16.351|-15.918|-12.454|2.2993|2.2993|-6.1814|56249.5||2.26|2.26
adr_usa_0533|ANCN|201912|18.211|17.575||1.357||4.846|4.121|0.725||14.909|-105.431||||0.4342||||0.6968|||0||0.1093|0.408|0.875|0|||||||7.4262|16|1.45||||1.434|9.205|9.051|22.939|1.4|1.4|-7.1871|27000.9667||1.5573|1.5573
adr_usa_0533|ANCN|202003|14.677|14.009||0.46||3.623|3.471|0.152||11.56|-108.966||||0.4831||||0.5045|||0||0.1816||0.602|0|||1|0.2754|||7.4199||-0.5||||1.825|-3.535|-3.535|0.01|0.786|0.786|-8.177|27629.4667|-88.4327|0.67|0.67
adr_usa_0533|ANCN|202006|9.672|8.824||0.293||1.859|1.751|0.108||8.157|-112.447||||-0.0728||||1.2462|||0||0.2395||0.974|0|||1|1.4254|||7.4199||-0.45||||2.176|-3.481|-3.481|0.002|1.37|1.37|1.3413|93399.1|-69.4196|1.39|1.39
adr_usa_0533|ANCN|202009|||||||||||||||0.0198||||1.037|||0||0.3027||||||2|0.8364|||||||||||||1.14|1.14|-0.3653|54246.0333|-50.4197|1.15|1.15